Loading clinical trials...
Loading clinical trials...
The study of new biological heart valves with the "easy change" system, including an assessment of the basic hemodynamic characteristics of the prosthesis, complications associated with valve implantation, and general mortality
The study of new biological heart valves with the "easy change" system, including an assessment of the basic hemodynamic characteristics of the prosthesis, complications associated with valve implantation, and general mortality. Antithrombotic therapy after new biological valve prosthesis is studied. Transesophageal ultrasound is used for assessment of aortic strain, left ventricular strain, and 3D reconstruction of implanted bioprosthesis. The quality of life of patients is assessed using SF36 questionnaire. Heart failure after surgery is assessed by six-minute walking test and plasma BNP level.
Age
60 - No limit years
Sex
ALL
Healthy Volunteers
No
Tomsk National Research Medical Center of the Russian Academy of Sciences
Tomsk, Tomsk Oblast, Russia
Start Date
November 29, 2016
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
May 6, 2023
500
ESTIMATED participants
valve prosthetics
PROCEDURE
Lead Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
NCT05208567
NCT03142152
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions